Yu-Ke Cen | Biochemistry | Research Excellence Award

Posted on by Phenomenological Research Awards

Mr.Yu-Ke Cen | Biochemistry | Research Excellence Award 

Associate Professor at Zhejiang University of Technology | China

Mr. Yu-Ke Cen is an accomplished biochemistry researcher with strong expertise in molecular microbiology, biosynthesis, and industrial biotechnology. He holds advanced academic training in bioengineering and biochemistry and has extensive experience in academic research and applied bioengineering. His research interests focus on fungal and yeast systems, drug resistance mechanisms, microbial cell factories, and enzymatic engineering. With 16 scientific documents, an h-index of 7, and 445 citations from 433 documents, Mr. Yu-Ke Cen demonstrates sustained research excellence and international scientific impact.

 Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
445

Documents
16

h-index
7

View Scopus Profile

Featured Publications

Yong-Yeon Cho | Biochemistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Prof. Yong-Yeon Cho | Biochemistry | Best Researcher Award

Professor at The Catholic University of Korea | South Korea

Prof.Yong-Yeon Cho is an accomplished biochemistry researcher recognized for his extensive contributions to molecular signaling, cancer biology, and drug development. His academic foundation includes rigorous training in biology, somatic cell genetics, and applied genetic engineering, forming the base for a career deeply rooted in experimental science and biochemical innovation. Over the years, he has held progressive research and academic positions, gaining broad expertise across molecular mechanisms of disease, pharmacological modulation, and therapeutic strategies. His research experience spans cellular signaling pathways, regulated cell death mechanisms, cancer chemoprevention, drug metabolism, nanoparticle-based delivery systems, immunological regulation, and translational pharmacology. He has made notable scientific contributions in areas such as ERK/RSK2 pathway targeting, UVB-induced autophagy, NLRP3 inflammasome regulation, organelle-targeted drug delivery, and the molecular foundations of metabolic and inflammatory diseases. His publication record reflects an exceptional level of productivity and global impact, with 186 peer-reviewed documents, 11,758 citations by 10,635 documents, and an impressive h-index of 49, demonstrating both the depth and influence of his work. His studies appear in leading journals across biochemistry, molecular biology, pharmacology, toxicology, and cancer research, highlighting his sustained commitment to advancing fundamental understanding while also bridging discoveries with potential clinical applications. His research interests continue to evolve across biochemical signaling networks, therapeutic biomaterials, immune regulation, toxicokinetics, and disease-associated molecular pathways, reflecting a multidisciplinary approach that integrates basic science with translational relevance. Throughout his career, he has collaborated on diverse scientific projects, contributed to international research initiatives, and helped develop emerging strategies for treating cancer, metabolic disorders, inflammatory diseases, and conditions driven by dysregulated cellular processes. Beyond producing high-impact research, he has also supported scientific progress through mentorship, scholarly leadership, and contributions to scientific discourse in multiple professional societies. His ongoing work continues to expand the boundaries of biochemistry and molecular medicine, positioning him as a leading figure whose research advances scientific knowledge while informing next-generation therapeutic innovations.

Profile: Scopus | Orcid | Google Scholar

Featured Publications:

Cho, Y.-Y.(2025). Loss of TC-PTP in keratinocytes leads to increased UVB-induced autophagy. Cell Death Discovery.

Cho, Y.-Y.(2025). Metabolite phenotyping of kobusin and identification of glutathione conjugates with kobusin catechol metabolite. Biomedicine & Pharmacotherapy.

Cho, Y.-Y.(2025). RSK2 and its binding partners: An emerging signaling node in cancers. [Journal name unavailable – Review article].

Cho, Y.-Y.(2025). Extracts from Allium pseudojaponicum Makino target STAT3 signaling pathway to overcome cisplatin resistance in lung cancer. Marine Drugs.

Cho, Y.-Y.(2024). SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death. Cellular and Molecular Life Sciences.

Cho, Y.-Y., Kim, M., Lee, S., et al. (2024). Safe and efficient treatment of drug-resistant colorectal cancer cells using kaempferol-loaded exosomes. Biotechnology and Bioprocess Engineering.

Cho, Y.-Y.(2024). RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth. Cell Death Discovery.

Cho, Y.-Y.(2024). Ribosomal S6 kinase 2–forkhead box protein O4 signaling pathway plays an essential role in melanogenesis. Scientific Reports.

Cho, Y.-Y.(2024). Hepatocyte-specific RIG-I loss attenuates metabolic dysfunction-associated steatotic liver disease in mice via changes in mitochondrial respiration and metabolite profiles. Toxicological Research.

Cho, Y.-Y.(2024). Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond. Advanced Drug Delivery Reviews.

Cara Lynne Schengrund | Biochemistry | Best Researcher Award

Posted on by Phenomenological Research Awards

Prof. Cara Lynne Schengrund | Biochemistry | Best Researcher Award 

Professor Emeritus at Penn State College of Medicine | United States

Prof. Cara Lynne Schengrund, Professor Emerita of Biochemistry and Molecular Biology at Penn State College of Medicine, is a renowned scientist whose career reflects a lifetime of impactful research and academic leadership. She completed her B.S. in Chemistry at Upsala College, followed by an M.S. and Ph.D. in Chemistry at Seton Hall University, building a strong foundation in chemical and biochemical sciences. Her professional journey includes roles as a research associate at Columbia University and Penn State before progressing through faculty ranks to Professor and later Professor Emerita, where she also served in leadership roles such as Acting Department Chair and Chair of the University Faculty Senate. Prof. Cara Lynne Schengrund ’s research has focused on the biological role of glycosphingolipids and gangliosides, particularly their involvement in neuroblastomas, neural development, cholesterol metabolism, and neurodegenerative diseases such as Alzheimer’s and autism. Her laboratory pioneered the synthesis of multivalent oligosaccharide inhibitors that block pathogen interactions, with implications for combating cholera, HIV, and other infectious diseases. possesses advanced research skills in neurochemistry, glycobiology, and biochemical analysis, with demonstrated expertise in lipid raft biology, receptor-ligand interactions, and therapeutic target identification. Her scholarly impact is evidenced by 2,563 citations across 2,054 documents, 87 publications, and an h-index of 28, highlighting both the breadth and depth of her scientific contributions. Prof. Cara Lynne Schengrund has been honored with prestigious recognitions including the Distinguished Alumni Award from Upsala College and the YWCA Tribute to Women of Excellence, and she has been elected to leadership positions in professional societies while serving on NIH and VA scientific review committees. With an enduring commitment to mentoring and international collaboration, she continues to influence biomedical research, and her groundbreaking work in glycosphingolipids and neurobiology positions her as a leader whose contributions will continue to shape advances in medicine and science globally.

Profile: Scopus

Featured Publications:

  • Thompson, J. P., & Schengrund, C. L. (1997). Oligosaccharide-derivatized dendrimers: Inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1. Glycoconjugate Journal, 14(7), 837–845.

  • Kensinger, R. D., Yowler, B. C., Benesi, A. J., & Schengrund, C. L. (2004). Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120. Bioconjugate Chemistry, 15(2), 349–358.

  • Petro, K. A., & Schengrund, C. L. (2009). Membrane raft disruption promotes axonogenesis in N2a neuroblastoma cells. Neurochemical Research, 34(1), 29–37.

  • Schengrund, C. L. (2015). Gangliosides: Glycosphingolipids essential for normal neural development and function. Trends in Biochemical Sciences, 40(7), 397–406. Schengrund, C. L. (2023). The yin and yang of ganglioside function in cancer. Cancers, 15(22), 5362.